Protagonist Therapeutics (PTGX) Debt Ratio (2018 - 2023)

Protagonist Therapeutics (PTGX) has 6 years of Debt Ratio data on file, last reported at 0.0 in Q2 2023.

• For the quarter ending Q2 2023, Debt Ratio fell 87.89% year-over-year to 0.0; the trailing twelve-month figure through Jun 2023 stood at 0.0 (down 87.89% YoY), and the FY2022 full-year result was 0.0, down 89.24% from the prior year.
• Debt Ratio retreated to 0.0 in Q2 2023, from 0.0 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.08 in Q1 2020 to a low of 0.0 in Q2 2023.
• A 5-year average of 0.01 and a median of 0.0 in 2019 frame the typical range for Debt Ratio.
• Across the five-year window, Debt Ratio surged 838.15% in 2019 and tumbled 99.09% in 2022, its largest moves.
• Tracing PTGX's Debt Ratio over 5 years: stood at 0.07 in 2019, then sank by 88.2% to 0.01 in 2020, then slumped by 69.29% to 0.0 in 2021, then plunged by 89.24% to 0.0 in 2022, then slumped by 88.79% to 0.0 in 2023.
• Business Quant data shows PTGX's Debt Ratio at 0.0 in Q2 2023, 0.0 in Q1 2023, and 0.0 in Q4 2022.